Literature DB >> 18302129

[Autism, epilepsy and mitochondrial disease: points of contact].

J J García-Peñas1.   

Abstract

INTRODUCTION: Autism is a neurodevelopmental disorder with unknown etiology, although several different specific organic conditions have been found to be associated with autism in about 10 to 37% of cases. Autism with regression has been reported in one third of autistic children with previously normal development. Epilepsy is quite common in autism spectrum disorders. The rate of comorbidity varies between 20-30% of cases, depending upon the age and type of disorder. Major risk factors for epilepsy in autistic children are mental retardation and additional neurological disorders, as well as some specific associated medical conditions like chromosomal abnormalities, phakomatosis and inherited metabolic disorders. AIM: To review the possible linkage between autism, epilepsy and mitochondrial dysfunction. DEVELOPMENT: The hypothesis of a disturbed bioenergetic metabolism underlying autism has been suggested by the detection of high lactate levels in some patients. Although the mechanism of hyperlactacidemia remains unknown, a likely possibility involves mitochondrial oxidative phosphorylation dysfunction in neuronal cells. Reduced levels of respiratory mitochondrial enzymes, ultraestructural mitochondrial abnormalities and a broad range of mitochondrial DNA mutations suggest a linkage between autism, epilepsy and mitochondrial disorders.
CONCLUSIONS: Though mitochondrial disorders are a rare cause of autism in children, we must keep in mind this etiology in autistic patients with epilepsy and associated signs of neurologic and/or systemic dysfunction. Finding biochemical or structural mitochondrial abnormalities in an autistic child does not necessarily imply a primary mitochondrial disorder but can also be secondary to technical inaccuracies or another genetic disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18302129

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis.

Authors:  Antoinette R Bailey; Brian N Giunta; Demian Obregon; William V Nikolic; Jun Tian; Cyndy D Sanberg; Danielle T Sutton; Jun Tan
Journal:  Int J Clin Exp Med       Date:  2008-10-15

Review 2.  Convulsing toward the pathophysiology of autism.

Authors:  Roberto Tuchman; Solomon L Moshé; Isabelle Rapin
Journal:  Brain Dev       Date:  2008-11-08       Impact factor: 1.961

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.